Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 35 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

6%

2 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (13)
P 2 (1)
P 4 (2)

Trial Status

Recruiting15
Not Yet Recruiting8
Completed6
Active Not Recruiting3
Enrolling By Invitation2
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (35)

Showing 20 of 20 trials
NCT07291960Not Yet Recruiting

Retinal Clinical Assessment With AI-derived Quantitative Information

NCT07378956Not ApplicableRecruitingPrimary

Clinical Efficacy of Implementing an AI-SaMD for Funduscopy Analysis in Patients With Diabetes Mellitus

NCT07526857CompletedPrimary

Epivascular Glia Regression and Macular Pigment Restoration After Faricimab in Diabetic Retinopathy

NCT07520045Not ApplicableRecruitingPrimary

Biomarkers in Diabetic Retinopathy Treated With Faricimab vs Biosimilar Ranibizumab

NCT07519707Not ApplicableRecruitingPrimary

Video Intervention to Improve Understanding of Diabetic Retinopathy at Zuckerberg San Francisco General Hospital and Trauma Center

NCT07456826Phase 4Recruiting

Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal Injections

NCT07497815Not Yet Recruiting

Artificial Intelligence-assisted Diagnosis in Ophthalmology

NCT07500324Not ApplicableRecruiting

Proteomic Biomarker Identification in AMD, Diabetic Retinopathy and Retinal Detachment

NCT07468058RecruitingPrimary

Diabetic Retinopathy Prevalence And Risk Factors

NCT07296952Not ApplicableRecruitingPrimary

Using Implementation Science to Adapt a Targeted Transportation Intervention for Patients With Diabetic Retinopathy (PRONTO-EYE)

NCT07404657Not Yet RecruitingPrimary

Preliminary Assessment of an Automated Tool for Diabetic Retinopathy Screening

NCT07386613Completed

Feasibility of Home Monitoring of Visual Function in DR

NCT07351786Recruiting

Impact of the New Generation Anti-diabetic Drugs on Diabetic Retinopathy

NCT07301775Phase 4Not Yet RecruitingPrimary

Comparing Single Versus Multiple Anti-VEGF Injections in Diabetic Patients Undergoing Cataract Surgery

NCT06457295CompletedPrimary

Impact of Diabetes Mellitus on Retinal Microvasculature in Patients Without Clinical Retinopathy Using Optical Coherence Tomography Angiography

NCT07222293RecruitingPrimary

Assessment of AI Program 'DRISTi' as a Screening Tool

NCT07249307Not Yet RecruitingPrimary

High-throughput Large-model-based AI-assisted Diagnosis Using OCT

NCT07069647Not ApplicableRecruiting

Artificial Intelligence-Aided Screening for Patients With Diabetic Retinopathy and Age-related Macular Degeneration in Family Medicine and Geriatric Medicine Outpatient Clinics

NCT06721351Not ApplicableActive Not RecruitingPrimary

Diabetic Retinopathy Screening Point-of-Care Artificial Intelligence

NCT07216677Active Not Recruiting

A Real-World Study of Interventional Clinical Outcomes in Patients With Open Angle Glaucoma and Other Chronic Eye Diseases

Scroll to load more

Research Network

Activity Timeline